Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Pharmasset LlcfiledCriticalGilead Pharmasset Llc
Publication of AR095133A1publicationCriticalpatent/AR095133A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se divulgan composiciones farmacéuticas que comprenden el Compuesto I, que tiene la fórmula (1) y una cantidad eficaz de sofosbuvir donde el sofosbuvir es sustancialmente cristalino. También se divulgan métodos para usar la composición farmacéutica.Pharmaceutical compositions comprising Compound I, having the formula (1) and an effective amount of sofosbuvir where sofosbuvir is substantially crystalline, are disclosed. Methods for using the pharmaceutical composition are also disclosed.
ARP140100355A2013-08-272014-01-31
FORMULATION OF COMBINATION OF TWO ANTIVIRAL COMPOUNDS
AR095133A1
(en)
Compounds derived from pyrrolo1,2-f1,2,4triazine, a pharmaceutical composition that comprises them and their use in the treatment of a syncytial virus infection intermediary compounds. pct